(Alliance News) - Fresnillo PLC on Tuesday reported higher sales and profit in 2025, as it benefited from soaring gold and silver prices, enabling the miner to declare its highest dividend since listing. Read More
(Alliance News) - Smiths Group PLC on Tuesday said it has agreed to buy a US provider of heating and cooling systems for data centres, a growing market due to spending on artificial intelligence computing. Read More
(Alliance News) - UK take-home grocery sales rose in February as shoppers continued to spend more at the tills and increasingly turned to online ordering, industry survey data showed on Tuesday. Read More
(Alliance News) - The FTSE 100 was called lower for the second day running on Tuesday, as war in the Middle East enters its fourth day while the UK waits for the chancellor's spring statement. Read More
(Alliance News) - The UK government has the "right economic plan for the country", Rachel Reeves will insist at the spring statement. Read More
(Alliance News) - Stocks in London are set to open lower on Tuesday, with oil and gold prices remaining elevated as geopolitical tensions remain high. Read More
(Alliance News) - Welcome to the Alliance News UK service (ISSN 2515-9453), consisting of the Alliance News UK Professional and its family of financial newswires serving investors and their professional advisers. Read More
ValiRx PLC - London-based life science company - Establishes wholly owned subsidiary ValiRx Animal Health Ltd to develop and commercialise its oncology assets in the veterinary market. The subsidiary will use preclinical work from ValiRx human programmes to pursue comparative oncology opportunities. "There is a strong scientific rationale, as well as market opportunities, for this ethical approach and several examples of companies that have followed this route," says Chief Executive Officer Mark Eccleston, who adds that the three key areas of focus will be Osteosarcoma, Lymphoma and Hemangiosarcoma. ValiRx said specialist veterinary venture capitalist funds have been identified and approached with the intention that the subsidiary will be independently funded. The global veterinary oncology market was valued at USD1.58 billion in 2024 and is projected to reach USD4.86 billion by 2034, representing a compound annual growth rate of 12%. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Zurich Insurance Group AG on Monday said it will partly fund its GBP8.1 billion acquisition of Beazley PLC via a private placement, with the remainder to be financed with existing cash and new debt facilities. Read More
(Alliance News) - Eco (Atlantic) Oil & Gas Ltd on Monday reported rising revenue and broadly stable pretax loss in the third quarter compared to a year ago, as the exploration company's strategic partnership with Navitas was reflected in its interim results. Read More
(Alliance News) - Keir Starmer defended his decision not to allow UK bases to be used by the US in the initial strikes against Iran in the face of criticism from Donald Trump. Read More
(Alliance News) - Shares in London nursed heavy losses on Monday, alongside peers in Europe, as US and Israeli strikes on Iran sparked fears of a drawn out conflict in the Middle East. Read More
Avation PLC - Singapore-based aircraft leasing company - Says it doesn't expect any direct financial impact from the conflict in the Middle East due to the geographical distributions of its customers. It also reports that it has entered into a letter of intent with a European airline for the lease of two ATR 72-600 which came back into Aviation's possession following the reconstruction of Braathens Regional Airways AB, a virtual airline based in Sweden. Five further ATR 72-600 will be delivered to the company between 2028 and 2029 as it has converted five of its 24 purchase rights into firm orders, bringing the undelivered ATR 72-600 order book to 14 planes. The purchases are expected to be fully funded by organic cash flows. Read More
(Alliance News) - SkinBioTherapeutics PLC on Monday announced Rachel Parsonage has been appointed as interim chief executive officer effective immediately as the life science firm tries to carve out a way forward from the suspension and resignation of its past CEO. Read More